BioSpace News Archive

Centene Corporation announced that it has successfully completed the previously announced divestiture of Magellan Rx to Prime Therapeutics LLC.

March of Dimes announces two early career scientists as recipients of the 2022 Basil O’Connor Starter Scholar Research Awards: Dr. Antonina Frolova, MD, PhD from Washington University, St. Louis and Dr. Isaac Marin-Valencia, MD, MS from Icahn School of Medicine at Mount Sinai.

ImmuneOncia (CEO Heung Tae Kim) announced the results of its Phase 2 NK/T-cell lymphoma clinical trial of IMC-001, a PD-L1 monoclonal antibody, at the Asian Congress of the European Society for Medical Oncology (ESMO Asia 2022) held in Singapore on December 4th, 2022.

Agendia, Inc., a leader in gene expression profiling for early-stage breast cancer, received acceptance for all six abstract submissions that will help guide the future of personalized cancer care and will be presented at the 2022 San Antonio Breast Cancer Symposium (SABCS).

Mammoth Biosciences, Inc., a biotechnology company building the next generation of CRISPR products with a mission to cure and detect diseases, announced the appointment of Phil Tinmouth as Chief Business Officer and Siang Chin as General Counsel.

BioAge Labs, Inc. (“BioAge”), a clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced positive Phase 1b clinical data for BGE-105, a highly selective, potent, orally available small-molecule agonist of the apelin receptor APJ.

Zephyr AI, Inc. (“Zephyr AI”), a high-growth healthcare technology company committed to radically reshaping traditional approaches to drug discovery and precision medicine, has announced the formation of a Scientific and Medical Advisory Board.

STEMTECH CORPORATION announces that Darryl V. Green, Board Director, Investor and Advisor, will be participating at the RHK Capital Disruptive Growth Conference in New York City.

Prolacta Bioscience® announced that Dr. David Dallas, PhD, of Oregon State University will present published data on the effects of various manufacturing methods on bioactive proteins in donor human milk at the Hot Topics in Neonatology® 2022 conference in National Harbor, Maryland, on Tuesday, Dec. 6, at 12:15 p.m.

Therapeutic Solutions International (TSOI) announced today preliminary results of a collaboration with the Veltmeyer Institute for Advanced Therapeutics aimed at providing patients with protocols, products and cells, developed by the Company.